Drug
KeraStat cream
KeraStat cream is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
100%(2 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
recruitingnot_applicable
M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis
NCT06441266
completednot_applicable
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy
NCT04173247
completednot_applicable
Skin Prick Test of KeraStat® Cream
NCT04058054
Clinical Trials (3)
Showing 3 of 3 trials
NCT06441266Not Applicable
M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis
NCT04173247Not Applicable
Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy
NCT04058054Not Applicable
Skin Prick Test of KeraStat® Cream
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3